Objectives Ceftaroline fosamil, the prodrug of the active metabolite ceftaroline, is a broad-
spectrum, parenteral cephalosporin approved for treatment of moderate to severe bacterial …

BACKGROUND: Ceftaroline is a cephalosporin with expanded gram-positive activity
recently approved for clinical uses by the US Food and Drug Administration. OBJECTIVE …

Objectives The objective of this study was to evaluate the in vitro antimicrobial activity of
ceftaroline and comparator agents tested against Staphylococcus aureus isolates causing …

Background Osteomyelitis is often challenging to treat. This analysis examined the clinical
experience of patients with gram-positive osteomyelitis treated with ceftaroline fosamil in the …

Study Objective To determine clinical outcomes in patients who received ceftaroline
(Teflaro) 600 mg intravenously every 8 or 12 hours after failing or developing intolerance to …

Abbreviations: CA-MRSA, community-associated MRSA; CLSI, Clinical and Laboratory
Standards Institute; EARSS, European Antimicrobial Resistance Surveillance System; HA …

Objective To assess the success rates of off-label uses of ceftaroline for infections caused by
methicillin-resistant Staphylococcus aureus (MRSA) and evaluate emerging ceftaroline …

Ceftaroline fosamil, the prodrug form of ceftaroline, is a novel broad-spectrum parenteral
cephalosporin that exhibits antibacterial activity against typical respiratory pathogens such …

The development of antimicrobial treatments for respiratory pathogens in cystic fibrosis (CF)
has been an integral component to the increased survival of CF patients over the past fifty …

Objective: To review the treatment of methicillin-resistant Staphylococcus aureus (MRSA)–
associated acute pulmonary exacerbations (APEs) in cystic fibrosis (CF). Data Sources: A …